Non categorizzato Roche to buy Poseida Therapeutics for $1.5B Novembre 26, 2024 0 commenti F. Hoffmann-La Roche AG announced on Tuesday that it is acquiring Poseida Therapeutics Inc. for around $9 per share in cash or $1 billion in total. Shareholders will also receive a non-tradeable conti… About the author:
Get involved!
Comments